Table 1 Serum lipid profiles across control and treated rat groups.

From: Cardioprotective effects of curcumin and piperine against obesity induced oxidative stress in rats

Parameters

Groups

    

Control

DMSO

Cur + Pip

HFD

HFD + Cur+Pip

Cholesterol (mg/dl)

     

 Mean ± SE

181.2 ± 6.644

183.2 ± 5.553

182.8 ± 3.99

390.4 ± 26.49 a

267.0 ± 18.60ab

 % of change

     

  1

 

+ 1.103

+ 0.883

+ 115.452

+ 47.351

  2

    

− 31.608

Triglycerides (mg/dl)

     

 Mean ± SE

145.0 ± 6.205

144.6 ± 4.343

148.0 ± 5.967

283.8 ± 6.733 a

192.6 ± 5.963 ab

 % of change

     

  1

 

− 0.275

+ 2.069

+ 95.724

+ 32.827

  2

    

− 32.135

HDL (mg/dl)

     

 Mean ± SE

87.20 ± 4.017

86.20 ± 1.655

86.40 ± 1.435

42.00 ± 3.536a

65.00 ± 2.302 ab

 % of change

     

  1

 

− 1.146

− 0.917

− 51.834

− 25.458

  2

    

+ 54.761

LDL (mg/dl)

     

 Mean ± SE

65.00 ± 9.377

68.08 ± 6.251

66.80 ± 4.552

291.6 ± 25.20 a

163.3 ± 17.81 ab

 % of change

     

  1

 

+ 4.738

+ 2.769

+ 348.615

+ 151.230

  2

    

− 43.9986

CRI-I (TC/HDL)

     

 Mean ± SE

2.09 ± 0.13

2.12 ± 0.09

2.11 ± 0.04

9.47 ± 0.78 a

4.10 ± 0.26 ab

 % of change

     

  1

 

+ 1.43

+ 0.95

+ 353.1

+ 96.1

  2

    

− 56.7

CRI-II (LDL/HDL)

     

 Mean ± SE

0.76 ± 0.13

0.79 ± 0.08

0.76 ± 0.05

7.10 ± 0.71 a

2.51 ± 0.26 ab

 % of change

     

  1

 

+ 3.94

+ 0.0

+ 834.2

+ 230.2

  2

    

− 64.6

AC (TC-HDL)/HDL

     

 Mean ± SE

1.09 ± 0.13

1.12 ± 0.09

1.11 ± 0.04

8.48 ± 0.78a

3.10 ± 0.26ab

 % of change

     

  1

 

+ 2.75

+ 1.83

+ 677.9

+ 184.4

  2

    

− 63.4

  1. Data are presented as mean ± SE (N = 6). a: Significant differences when compared to the control group (P ≤ 0.05). b: Significant differences when comparing HFD + Cur+Pip to the HFD group (P ≤ 0.05). (1%): Percentage change compared to the control group. (2%): Percentage change compared to the HFD group.